Navigation Links
Statins Don't Cut Cancer Risk
Date:2/5/2009

Animal study found 2 popular cholesterol-lowering drugs had little effect on tumors

THURSDAY, Feb. 5 (HealthDay News) -- Statins have clearly proven their mettle against heart disease, but the cholesterol-lowering drugs don't appear to possess cancer-fighting powers, a new animal study shows.

"We certainly didn't see any positive effects," said Ronald Lubet, program director in the division of cancer prevention at the National Cancer Institute. He led the study using mice and rats, which was published in the February issue of Cancer Prevention Research.

Lubet and his colleagues studied the effects of two popular cholesterol-lowering drugs, atorvastatin (Lipitor) and lovastatin (Mevacor), in warding off breast cancer. "The initial dose was about twice as high as what a person would typically use," he said. "The second dose was even higher."

Some researchers were hoping statins might have a double-edged effect, reducing heart disease risk as well as guarding against cancer. For instance, one recent study found that men who took statins had lower blood levels of prostate-specific antigen (PSA), a biomarker for prostate cancer risk.

And in a report published in the Journal of the National Cancer Institute in 2006, researchers found statins were associated with lower breast cancer incidence among women in the large-scale Women's Health Initiative trial and called for further study of the possible link.

Exactly how statins might fight cancer isn't certain. But Lubet's group did not see any such potential with the statins it tested.

The researchers gave Lipitor at a dose of either 125 milligrams or 500 milligrams per kilogram of body weight to the animals, mixing it into their diet, but it showed no anti-cancer effect.

They also compared the use of the anti-cancer drugs tamoxifen and bexarotene by themselves and with atorvastatin. The anti-cancer drugs reduced breast tumors in the animals, but adding the statin did not improve the effect.

The researchers also gave lovastatin at 100- and 500-milligram per kilogram of body weight to the animals but again did not uncover any cancer-fighting effects.

"In these two relatively standard animal models, [the statins] were not effective in preventing the development of tumors," Lubet said.

Lubet's group conducted the study, because the data to date has been mixed, with some studies showing the statins helped prevent cancer but others not. They wanted to see if clinical trials with humans, which are expensive, were warranted.

"To go to a large-scale trial, this [study] would not support it," Lubet said.

The new finding reflects the evidence to date from human studies, said Eric J. Jacobs, strategic director of pharmacoepidemiology at the American Cancer Society in Atlanta.

"The totality of the evidence from human studies also indicates that statins are unlikely to reduce the risk of breast cancer," Jacobs said. "While statins are proven effective in saving lives from heart disease, they should not be used in the hope of reducing the risk of cancer."

What would help?

"Maintaining a healthy weight will reduce a woman's risk of developing breast cancer, as well as many other serious health problems," he said.

More information

To learn more about statins, visit the American Heart Association.



SOURCES: Eric Jacobs, Ph.D., American Cancer Society, Atlanta; Ronald Lubet, Ph.D., program director, division of cancer prevention, National Cancer Institute, Rockville, Md.; February 2009, Cancer Prevention Research; Oct. 28, 2008, and May 17, 2006, Journal of the National Cancer Institute


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Got High Cholesterol? Statins Are Not the Only Answer, Says Natural Solutions Magazine
2. Millions More Americans Might Be Placed on Statins
3. Statins Help Prevent Delirium After Heart Surgery
4. WomenHeart Urges Women to Talk With Doctors About New Study Showing Statins Prevent Heart Attacks, Deaths
5. Statins Lower Blood Marker for Prostate Cancer
6. Statins Reduced Death Risk From Pneumonia
7. Statins Lower Risk of Clots in Cancer Patients
8. Statins show promise for blood clot prevention
9. Statins Show Promise for Blood Clot Prevention
10. Statins Help Obese People After Bypass Surgery
11. Research Shows Why Statins Dont Work for Everyone
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statins Don't Cut Cancer Risk
(Date:4/24/2017)... , ... April 24, 2017 , ... My T Chai, ... its products are now available for purchase on RevNutrition.com, a popular website specializing in ... first produced and popularized in ancient India and Siam. It spread across Asia and ...
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading ... today announced that Kyle Allain has joined the company as Vice President and ... operations, including provider, payor and managed care solutions. , A seasoned executive ...
(Date:4/24/2017)... ... 24, 2017 , ... In 2017, up to 78,000 new ... of them will be malignant.(1) As research into precision medicine continues, both patients ... in the diagnosis and treatment of brain tumors. Healthcare facilities that are already ...
(Date:4/24/2017)... ... 2017 , ... Rod Burkett, CEO of Gardant Management Solutions, was recently featured ... at the forefront of Gardant since it was founded in 1999. His drive and ... of more than 40 new senior living communities. With his leadership, Gardant has grown ...
(Date:4/24/2017)... ... ... As a former supermodel known for her timeless beauty, Joan Severance knows ... is that she put all the words in her new book, "Manifest Your Mate: ... and sparkling sense of humor have inspired her to write a book on how ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... -- Research and Markets has announced the addition of ... Expanding Injectables Market and Increasing Usage of Complex Biologics during the ... ... from USD 20 Billion in 2015 to around USD 26 Billion ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology: